Vis enkel innførsel

dc.contributor.advisorMelbye, Hasse
dc.contributor.authorMedbø, Astri
dc.date.accessioned2012-10-04T08:40:30Z
dc.date.available2012-10-04T08:40:30Z
dc.date.issued2012-11-09
dc.description.abstractSUMMARY Smokers benefit from the enjoyment and fellowship smoking brings in the short term, yet may cause diseases and disability later in life. This thesis is about COPD, the spirometry criteria for diagnosis, the predictive value of respiratory symptoms, and smoking and its cessation. Paper 1 and 2 are quantitative, epidemiological studies, which were based on a cross sectional population study in the city of Tromsø, Norway, in 2001. We chose to do our research on people aged 60 years and above since COPD is usually detected in this age group, and we had access to a representative sample from the Tromsø 5 study. In addition to spirometry the papers are based on data from questionnaires. The research question in paper 1was: Can we use FEV1 /FVC<70% as a criterion of COPD in all ages? Main results paper 1: The frequency of FEV1 /FVC ratio <70% was approximately 7% in never smokers aged 60–69 years compared to 16–18% in those of 70 years of age or more (p<0.001). FEV1 /FVC ratio <70% among never smokers aged 60–69 years was as frequent as FEV1 /FVC ratio <65% among never smokers older than 70 years. Conclusion: Adjustments of the GOLD criteria for diagnosing COPD are needed, and FEV1 / FVC ratios down to 65% should be regarded as normal when aged 70 years and older. The research question in paper 2 was: What role may symptoms play in the diagnosis of airflow limitation? Main results paper 2: The prevalence of any airflow limitation, (defined as FEV1 /FVC ratio <70% in subjects <70 years old and <65% in subjects ≥70 years old) was 15.5% and 20.8%, in women and men, respectively. Whereas the corresponding prevalences of severe airflow limitation (FEV1 <50% predicted) were 3.4% and 4.9%. The increased risk of having any airflow limitation corresponded to an OR 2.4 among ex-smokers and OR 5.8 among current smokers compared to never smokers. The prevalence of airflow limitation was more than doubled amongst never-and ex-smokers when two or more of the symptoms wheeze, dyspnoea or cough with phlegm were reported, compared to only one. Ex-smokers reporting two symptoms had a similar risk of airflow limitation as current smokers not reporting any symptoms. Conclusion: Respiratory symptoms are valuable predictors of airflow limitation, and should be emphasized when selecting patients for spirometry. Paper 3 is a qualitative document, based on interviews with 18 participants of 58 years of age and older. Research question in paper 3: “What makes people start smoking, and a smoker to quit and maintain quitted?” Main results: The influence of “all the others” is essential when starting to smoke. In the process of stopping smoking, relapses and continued smoking, the spouses have a vital influence. Smoking cessation often seemed to be unplanned. Finally with an increasingly negative social attitude towards smoking, increased the informant`s awareness of the risks of smoking. Conclusion: “All the others” is a clue in the smoking story. For smoking cessation, it is essential to be aware of the influence of friends and family members, especially a spouse. People may stop smoking unplanned, even when motivation is not obvious. Information from the community and doctors on the negative aspects of smoking should continue. Eliciting life-long smoking narratives may open up for a fruitful dialogue, as well as prompting reflection about smoking and adding to the motivation to stop.en
dc.description.doctoraltypeph.d.en
dc.description.popularabstractKOLS (kronisk obstruktiv lungesykdom) øker på verdensbasis og er en av de mest dødelige sykdommene vi har. I ca. 90 % av tilfellene i den vestlige verden skyldes KOLS røyking. Diagnosen stilles ut fra pusteprøven spirometri, og utviklingen kan følges med samme testen. Ofte stilles diagnosen seint i forløpet. Det finnes ikke medisiner som kan helbrede KOLS, men noen tiltak kan bremse utviklingen. Det å slutte å røyke er det viktigste enkelttiltaket. I avhandlingen har vi sett på hvordan vi skal stille diagnosen KOLS hos personer over 60 år. Lungefunksjonen faller med økende alder, og den faller betydelig raskere hos røykere. Global Initiative for Chronic Obstructive Lung Disease (GOLD) definerer at KOLS forekommer når lungefunksjonsmålet FEV1/FVC <70 %. Om man bruker denne definisjonen i alle aldre vil man overdiagnostisere personer over 70 år. Vi foreslår å senke grensen for å definere KOLS til FEV1/FVC< 65 % hos personer over 70 år. De vanligste symptomene på KOLS er tungpustethet, kronisk hoste (med eller uten oppspytt) eller piping i brystet. Vi ville også undersøke om man kunne stille diagnosen KOLS kun på symptomer, og hvilken verdi symptomer har. Symptomene har en viss verdi for å stille diagnosen KOLS, og jo flere symptomer, jo større sjanse er det for at KOLS forekommer. Likevel er det aller viktigste informasjonen om en er røyker. Livet forkortes i gjennomsnitt med 14- 20 år pga røyking Andelen daglig røykere faller i Norge og en del vestlige land. Likevel er fortsatt 20 % (ca 800.000 nordmenn) dagligrøykere.. I den siste artikkelen i avhandlingen ville vi undersøke hva som får folk til å slutte å røyke, og forbli røykfri. De fleste motivasjons modeller for livsstilsendringer er kun fokusert på den enkeltes omsorg for egen helse, ikke på hvilken påvirkning de får fra omverdenen. Vi fant at ”alle andre” har en sterk innflytelse på røykere. ”Alle andre”(dvs venner og slektninger) påvirker unge mennesker til å starte å røyke. ”Alle andre” (dvs ektefelle/samboer) påvirker en røyker til å fortsette å røyke, eller å slutte eller å sprekke. Vi fant også at en røyker ikke nødvendigvis må bruke preparater for å slutte, og at plutselige hendelser eller bestemmelser like gjerne kan gjøre en røykfri som det å planlegge via motivasjonsstratergier.en
dc.description.sponsorshipUniversitetet i Tromsø og litt støtte fra Allmennmedisinsk Forsknings Fonden
dc.descriptionPapers 1 & 2 of this thesis are not available in Munin: <br/>1. Medbo A & Melbye H.: 'Lung function testing in the elderly-Can we still use FEV1/FVC<70% as a criterion of COPD?', Respiratory Medicine (2007), vol.101:1097-1105. Available at <a href=http://dx.doi.org/10.1016/j.rmed.2006.11.019>http://dx.doi.org/10.1016/j.rmed.2006.11.019</a>. <br/>2. Medbo A & Melbye H.: 'What role may symptoms play in the diagnosis of airflow limitation?', Scandinavian Journal of Primary Health Care (2008), vol.26:2, pp.92-98. Available at <a href=http://dx.doi.org/10.1080/02813430802028938>http://dx.doi.org/10.1080/02813430802028938</a>en
dc.identifier.isbn978-82-7589-367-1
dc.identifier.urihttps://hdl.handle.net/10037/4537
dc.identifier.urnURN:NBN:no-uit_munin_4263
dc.language.isoengen
dc.publisherUniversity of Tromsøen
dc.publisherUniversitetet i Tromsøen
dc.relation.ispartofseriesISM skriftserie, nr 130
dc.rights.accessRightsopenAccess
dc.rights.holderCopyright 2012 The Author(s)
dc.subject.courseIDDOKTOR-003en
dc.subjectMedisinen
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin, sosialmedisin: 801en
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800::Community medicine, Social medicine: 801en
dc.subjectKOLSen
dc.subjectrøykingen
dc.subjectsmokingen
dc.subjectCOPDen
dc.subjectThe Tromsø Study
dc.subjectTromsøundersøkelsen
dc.titleCOPD in the elderly : diagnostic criteria, symptoms and smoking. Quantitative and qualitative studies of persons over sixty years of age in The Tromsø studies.en
dc.typeDoctoral thesisen
dc.typeDoktorgradsavhandlingen


Tilhørende fil(er)

Thumbnail
Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel